AlloVir, Inc.
ALVR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $47,935 | $69,980 | $388,909 | $803,463 |
| - Cash | $118,289 | $90,121 | $106,092 | $201,661 |
| + Debt | $0 | $27,429 | $35,387 | $30,066 |
| Enterprise Value | -$70,354 | $7,288 | $318,204 | $631,868 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$398 | -$2,565 | -$1,117 |
| % Margin | – | – | – | – |
| EBITDA | -$65,441 | -$190,146 | -$166,410 | -$169,838 |
| % Margin | – | – | – | – |
| Net Income | -$58,769 | -$190,418 | -$168,710 | -$171,962 |
| % Margin | – | – | – | – |
| EPS Diluted | -11.73 | -42.09 | -50.6 | -63.02 |
| % Growth | 72.1% | 16.8% | 19.7% | – |
| Operating Cash Flow | -$67,705 | -$124,451 | -$142,052 | -$106,319 |
| Capital Expenditures | $0 | $0 | $104 | -$26 |
| Free Cash Flow | -$67,705 | -$124,451 | -$141,948 | -$106,345 |